Prehospital
Literature Index
Neurology

Clinical efficacy of clonazepam in the treatment of status epilepticus.

Xiaomeng Zhou, Liang Fang, Xuefei Tong, Ying Xu, Xue Wu

Pakistan Journal of Pharmaceutical Sciences · 2022-05-01 · Randomised trial

PubMed

Abstract

To explore the clinical efficacy of clonazepam in the treatment of status epilepticus. Totally 60 patients with status epilepticus were identified as research subjects and assigned (1:1) via the randomized double-blind method to receive either diazepam (Valium) comparison group) or clonazepam (observation group). After treatment and follow-up visits, the treatment efficacy, incidence of adverse reactions, quality of life, and recurrence were evaluated and compared between the two groups. The total effective rate of the observation group was 93.33%, which was higher than that of 66.67% in the comparison group (P<0.05). A longer mean duration of drug effect was observed in the observation group than in the comparison group (P<0.05). The observation group outperformed the comparison group in terms of quality of life (P<0.05). The observation group had a lower incidence of adverse reactions than the comparison group (P<0.05). The overall recurrence rate in the comparison group was 23.33%, which was significantly higher than that of 6.67% in the observation group (P<0.05). Clonazepam yields a promising efficacy in the treatment of patients with status epilepticus.

Abstract © the authors or publisher, via PubMed. Reuse and removal

Tags

Sedatives & anxiolytics · Diazepam · Other benzodiazepines & Z-drugs

Related articles